Common questions about Fontrax (FAQ)
Q: Can Fontrax be taken with common pain relievers like ibuprofen?
Regulatory documents advise caution when taking Fontrax with medications that inhibit platelet function, such as ibuprofen. This is due to a potential increase in the overall risk of bleeding events when the drugs are combined. Regulatory documents suggest that this interaction should be discussed with a healthcare professional.
Q: Are there any foods or drinks that should be avoided when taking Fontrax?
The regulatory label specifies that grapefruit and grapefruit juice should be avoided. This is due to the potential for these products to increase the drug's concentration in the blood. Otherwise, Fontrax can typically be taken with or without food, provided the administration time is consistent.
Q: Is Fontrax generally considered safe for long-term use?
Clinical studies have involved long-term follow-up of patients for five years or more, providing extensive data. However, official information notes that a serious adverse reaction, Pulmonary Arterial Hypertension (PAH), can develop at any time during long-term therapy. Continued monitoring of patients is part of the long-term use protocol.
Q: What are the long-term effects described in studies of Fontrax?
Long-term follow-up analyses in studies tracked adverse reactions over periods of up to seven years. Reactions that were observed over this time included diarrhea, hemorrhage (bleeding), and fluid retention. These findings provide context on the persistence of certain effects in the study populations.
Q: Can I take vitamins or supplements while on Fontrax?
Official documents advise caution with supplements, particularly those that are potent CYP3A4 inducers (substances that affect drug metabolism). The herbal product St. John’s Wort is specifically named as one that should be avoided because it may decrease the level of Fontrax in the blood.
Q: What if I have an allergic reaction to Fontrax—what should I look out for?
Severe hypersensitivity reactions have been reported in official documents. Symptoms that have been reported and may require attention include fever, rash, swelling of the face, lips, mouth, or throat, or trouble swallowing. The medicine is contraindicated in patients with a known hypersensitivity.
Q: How does Fontrax affect the liver or kidneys?
Hepatotoxicity (liver damage), including severe cases, has been reported in official regulatory documents. It is required that liver function tests be assessed before starting and monitored regularly during treatment. The regulatory label advises caution when Fontrax is used in patients with hepatic impairment.
Q: Can I use Fontrax if I have a history of heart problems?
Official prescribing information advises caution for individuals with a history of heart problems. These issues include conditions that cause QT prolongation (a heart rhythm issue) and a history of heart attack. The label notes that these cardiovascular risk factors require specific monitoring.
Q: What is the pregnancy safety category of Fontrax?
Regulatory documents indicate that Fontrax can cause fetal harm (Embryo-Fetal Toxicity). The US FDA label uses the updated Pregnancy and Lactation Labeling Rule (PLLR) for risk assessment, and therefore does not use the old pregnancy category letters (A, B, C, D, or X).
Q: Can Fontrax affect how well birth control pills work?
Females of reproductive potential are required to use effective contraception during and for at least one month after treatment to avoid the risk of fetal harm. Specific interactions that might reduce the effectiveness of hormonal birth control pills are not explicitly detailed in the label.
Q: What ingredients are in the Fontrax pill besides the main drug?
The tablets contain the active therapeutic substance, Dasatinib, along with standard inactive ingredients, or excipients. Official product information indicates that these inactive components include lactose monohydrate.
Q: What is the relationship between Fontrax and the body's immune system?
The medicine affects the blood and lymphatic system by causing myelosuppression. This condition results in low blood cell counts, which can decrease the body’s overall ability to fight infection. The risk of low blood cell counts is higher in advanced disease phases.
Q: Does the dose of Fontrax depend on a person's weight?
Yes, the starting dose for pediatric patients is based on body weight and must be adjusted as the child grows. The standard starting dose for adult patients, however, is determined by the disease phase being treated.
Q: Is it normal to feel a bit nauseous when first starting Fontrax?
Yes, official safety information lists nausea as a Very Common or Common adverse reaction. This means it has been frequently observed in patients receiving the medicine in clinical settings. Other gastrointestinal disorders have also been reported.
Q: Can Fontrax interact with other mental health medications?
Caution is required with many mental health medications because Fontrax can interact with drugs that affect the heart's QT interval (a heart rhythm measure). Regulatory documents advise caution when combining Fontrax with any drug that is known to prolong the QT interval.
Q: How quickly does Fontrax usually start working?
Pharmacokinetic studies in regulatory documents describe the time it takes for the drug to enter the body. The maximum concentration of Fontrax in the blood is generally reached between 0.5 and 6 hours after the dose is taken. This measurement indicates when the drug is most concentrated in the body.
Q: Is Fontrax safe for older adults to use?
Official prescribing information indicates that no specific dose adjustment is required for geriatric patients based solely on age. The safety profile observed in older patients is generally similar to that seen in younger adults.
Q: Does Fontrax cause changes in weight?
Weight gain is listed as a Common adverse reaction in the official safety information. This effect is often associated with the fluid retention (edema) that is also frequently reported.
Q: Is it true that Fontrax can affect sleep?
Yes, Insomnia (difficulty sleeping) is listed as a Common adverse reaction in the official product information. This means it has been observed in more than 1% of patients in clinical trials.
Q: Do I need a special blood test before starting Fontrax?
Before starting treatment, patients must have a complete blood count (CBC) and liver function tests assessed. Screening for Hepatitis B Virus (HBV) and correcting any low levels of potassium or magnesium may also be required.
Q: Does Fontrax have a 'black box warning' in the US?
Yes, the US FDA label includes a prominent Boxed Warning, which is sometimes referred to as a 'black box warning.' This warning highlights the risk of severe side effects, specifically myelosuppression (low blood cell counts).
Q: Is there a generic version of Fontrax available?
Yes, a generic version of the active ingredient, dasatinib, is available.
Q: Is Fontrax associated with mood changes or depression?
Depression is listed as a Common adverse reaction in the official safety information. This is a known effect that has been observed in patients during clinical use.
Q: Is Fontrax a controlled substance?
No, Fontrax (dasatinib) is not currently scheduled or classified as a controlled substance by the US Drug Enforcement Administration (DEA).
Q: Does using Fontrax affect fertility?
Animal studies generally indicated no negative effect on the fertility of rats. Regulatory information notes that male patients of reproductive potential may be advised about potential effects.
Q: Is Fontrax a new medicine or has it been around for a while?
The active ingredient, dasatinib, was first approved for use in the US in 2006. This indicates that the medicine has been available and studied for a considerable amount of time.
Q: Does Fontrax cause dry mouth or changes in taste?
Taste disturbance (dysgeusia) is listed as a Common side effect in the official safety profile. Dry mouth is also noted, though it is reported less frequently.
Q: What does the official label say about alcohol consumption while on Fontrax?
The official labels do not contain specific information prohibiting alcohol consumption. However, caution is generally recommended when combining the medicine with any substance that may increase its side effects or interfere with its effectiveness.
Q: Can Fontrax make me more sensitive to the sun?
Photosensitivity (increased sensitivity to sunlight) is listed as a reported adverse reaction in the official safety documents. Patients are often advised to take precautions against sun exposure.
Q: Are there warnings about driving or operating machinery while taking Fontrax?
Caution is recommended when driving a car or operating machinery. This is because the medicine may cause central nervous system side effects such as dizziness and blurred vision.
Q: Are there any known withdrawal effects described for stopping Fontrax?
Official documentation states that the effects of stopping treatment after achieving a complete molecular response have not been formally investigated. Therefore, there is no official description of specific withdrawal effects.
Q: Can Fontrax cause dizziness or lightheadedness?
Dizziness is listed as a Common adverse reaction in the official safety profile. This effect may impact a person's ability to drive or operate machinery.
